Management tracks

Cancer company Infinity Pharmaceuticals Inc. (NASDAQ:INFI) said President of R&D Julian Adams will retire, effective Jan. 6. The company

Read the full 198 word article

How to gain access

Continue reading with a
two-week free trial.